Literature DB >> 2689111

Eosinophil infiltration in primary esophageal achalasia. A possible pathogenic role.

A Tøttrup1, K Fredens, P Funch-Jensen, S Aggestrup, R Dahl.   

Abstract

Smooth-muscle specimens from the lower esophagus of nine patients operated on for esophageal achalasia were examined with routine hematoxylin-eosin staining. This procedure revealed only a few eosinophils in or between the external smooth-muscle layers. Using specific immunohistochemical methods for the detection of the eosinophil cationic protein (ECP), however, varying degrees of eosinophil infiltration and extracellular deposit of ECP were disclosed in the achalasia specimens. The ECP also reacted with the monoclonal antibody, EG2, indicating secretion of the cytotoxic ECP. Few or no eosinophils were seen in the muscularis externa in specimens from six control patients without esophageal disease. In two controls many eosinophils were observed in the muscularis externa. However, no extracellular ECP was detected and very few eosinophils reacted with the monoclonal antibody (EG2), suggesting that these eosinophils were not activated. Depletion or total absence of peptidergic innervation was seen in all achalasia specimens but not in controls. Since the eosinophil cationic protein (ECP), in its activated form, is cytotoxic, we propose a pathogenic role of the eosinophil infiltration in achalasia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2689111     DOI: 10.1007/bf01536708

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage.

Authors:  K Fredens; H Dybdahl; R Dahl; U Baandrup
Journal:  APMIS       Date:  1988-08       Impact factor: 3.205

2.  Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.

Authors:  S J Qualman; H M Haupt; P Yang; S R Hamilton
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

3.  Eosinophilic gastroenteritis with obstruction. Immunological studies of seven patients.

Authors:  J H Caldwell; H S Mekhjian; P E Hurtubise; F M Beman
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

4.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

5.  Regulatory peptides in the lower esophageal sphincter of man.

Authors:  S Aggestrup; R Uddman; S L Jensen; F Sundler; O Schaffalitzky de Muckadell; J J Holst; R Håkanson; R Ekman; H R Sørensen
Journal:  Regul Pept       Date:  1985-03

6.  Ultrastructure of the esophageal muscle in achalasia and diffuse esophageal spasm.

Authors:  D L Friesen; R D Henderson; W Hanna
Journal:  Am J Clin Pathol       Date:  1983-03       Impact factor: 2.493

7.  Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia.

Authors:  R H Holloway; W J Dodds; J F Helm; W J Hogan; J Dent; R C Arndorfer
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

8.  Achalasia of the cardia: pharmacology and histopathology of isolated cardiac sphincteric muscle from patients with and without achalasia.

Authors:  J J Misiewicz; S L Waller; P P Anthony; J W Gummer
Journal:  Q J Med       Date:  1969-01

9.  Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia.

Authors:  S Aggestrup; R Uddman; F Sundler; J Fahrenkrug; R Håkanson; H R Sørensen; G Hambraeus
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

10.  Gastroesophageal sphincter pressure and histological changes in distal esophagus in patients with achalasia of the esophagus.

Authors:  A Csendes; G Smok; I Braghetto; C Ramirez; N Velasco; A Henriquez
Journal:  Dig Dis Sci       Date:  1985-10       Impact factor: 3.199

View more
  17 in total

1.  Achalasia in a patient with adult-onset Tay-Sachs disease.

Authors:  Jeffrey W Nathanson; Charles S Winans
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

2.  Esophageal functional impairments in experimental eosinophilic esophagitis.

Authors:  Parm Mavi; Priya Rajavelu; Madhavi Rayapudi; Richard J Paul; Anil Mishra
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-23       Impact factor: 4.052

3.  New Eosinophilic Esophagitis Concepts Call for Change in Proton Pump Inhibitor Management Before Diagnostic Endoscopy.

Authors:  Eunice Odiase; Armond Schwartz; Rhonda F Souza; Jason Martin; Vani Konda; Stuart Jon Spechler
Journal:  Gastroenterology       Date:  2018-03-03       Impact factor: 22.682

4.  Association of achalasia and eosinophilic esophagitis.

Authors:  Rohan Mandaliya; Anthony J DiMarino; Sidney Cohen
Journal:  Indian J Gastroenterol       Date:  2012-10-03

5.  Achalasia due to eosinophil infiltration: fact or fiction?

Authors:  F Man; J C Chiocca
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

6.  Esophageal motor disorders in adults with eosinophilic esophagitis.

Authors:  Fouad J Moawad; Corinne L Maydonovitch; Ganesh R Veerappan; John T Bassett; Jason M Lake; Roy K H Wong
Journal:  Dig Dis Sci       Date:  2011-03-18       Impact factor: 3.199

Review 7.  Mechanism of eosinophilic esophagitis.

Authors:  Anil Mishra
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

8.  Selective fluorescence of eosinophilic structures in grasshopper and mammalian testis stained with haematoxylin-eosin.

Authors:  J Espada; P Valverde; J C Stockert
Journal:  Histochemistry       Date:  1993-05

Review 9.  Esophageal dysmotility in patients who have eosinophilic esophagitis.

Authors:  Samuel Nurko; Rachel Rosen
Journal:  Gastrointest Endosc Clin N Am       Date:  2008-01

10.  Idiopathic hypereosinophilic syndrome presenting with hepatitis and achalasia.

Authors:  Amanda C Cheung; Christine Y Hachem; Jinping Lai
Journal:  Clin J Gastroenterol       Date:  2016-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.